Moreover, emerging data have suggested that over-expression of PD-L1 on tumor cells by IHC correlates with inferior prognosis across many cancers but better response to anti-PD-1/PD-L1 therapy10, 12, 14, 15, 16, 17. Here, CD274 is linked to cancer.